Abstract
The protective effects of n-3 fatty acids in vascular atherosclerotic diseases, as shown in a number of epidemiological and experimental studies, have led to the proposition that these compounds may interfere with platelet-vessel wall interactions, a process which is pivotal in the development of thrombosis and, possibly, of atherosclerosis. That n-3 fatty acids interfere with platelet-vessel wall interactions is simply demonstrated by the fact, now established beyond any reasonable doubt, that they are able to prolong the bleeding time. Bleeding time is a “global” test exploring platelet reactions to a standardized interruption of vascular integrity; actually it appears to be the only test practically available to explore these interactions in vivo, in humans, in an integrated way; it suffers however from methodological problems (some variability in technique) and from theoretical flaws: its relationship with actual bleeding in other parts of the body is not proven; its value — on the other hand — as a thrombotic predictor is also unproven; finally, because of its “globality”, it does not provide insights into the mechanism(s) involved in its alterations. Therefore a “dissection” of the effects of n-3 fatty acids on platelet-vessel wall interactions requires the analysis of:
-
1.
studies on isolated platelets;
-
2.
studies on the isolated vessel wall;
-
3.
studies of interaction products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dyerberg J., Bang H.O., Stofferson E., Moncada S., Vane J.R.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978; 1: 117–119
Fischer S., Weber P.C.: Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 w-3). Biochem Biophys Res Commun 1983; 116: 1091–1099
von Schacky C., Fischer S., Weber P.C.: Long-term effects of dietary marine w-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest. 1985; 76: 1626–1631
Lands W.E.M., Culp B.R., Hirai A., Gorman R.: Relationship of thromboxane generation to the aggregation of platelets from humans: effects of eicosapentaenoic acid. Prostaglandins 1985; 30: 819–825
De Caterina R., Giannessi D., Mazzone A., Bernini W., Lazzerini G., Maffei S., Cerri M., Salvatore L., Weksler B.: Vascular prostacyclin is increased in patients ingesting w-3 polyunsaturated fatty acids before coronary artery bypass surgery. Circulation 1990; 82: 428–438
Braden G.A., Knapp H.R., Fitzgerald D.J., FitzGerald G.A.: Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo. Circulation 1990; 82: 178–187
FitzGerald G.A., Smith B., Pedersen A.K., Brash A.R.: Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N. Engl. J. Med. 1984; 310: 1065 1068
Knapp H.R., Reilly I.A.G., Alessandrini P., FitzGerald G.A.: In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 1986; 314: 937–942
Slack J.D., Pinkerton C.A., Van Tassel J., On C.M., Scott M., Allen B., Nasser W.K.: Can oral fish oil supplement minimize re-stenosis after percutaneous transluminal coronary angioplasty ? J. Am. C.ll. Cardiol. 1987; 9: 64A
Dehmer G.J., Popma J.J., van den Berg E.K., Eichhorn E.J., Prewitt J.B., Campbell W.B., Jennings L., Willerson J.T., Schmitz J.M.: Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N. Engl. J. Med. 1988; 319: 733–740
Milner M.R., Gallino R.A., Leffingwell A., Descalzi Pichard A., Brooks-Robinson S., Rosenberg J., Little T., Lindsay J.: Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1989; 64: 294–299
Roy L., Bairati I., Meyer F., Genest M.B.: Double-blind randomized controlled trial of fish oil supplements in the prevention of restenoses after coronary angioplasty. Circulation 1991; 11–365 (abstract 14)
ShimokawaH., Vanhoutte P.M.: Dietary cod-liver oil improves endothelium dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421 1430
Hansen J.B., Olsen J.O., Wilsgard L., Osterud B.: Effect of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J. Int. Med. 1989; 225Suppl 1: 133–139
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag London
About this paper
Cite this paper
De Caterina, R. (1992). n-3 Fatty Acids and Platelet-Vessel Wall Interactions. In: De Caterina, R., Kristensen, S.D., Schmidt, E.B. (eds) Fish Oil and Vascular Disease. Current Topics in Cardiovascular Diseases. Springer, London. https://doi.org/10.1007/978-1-4471-3890-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3890-7_7
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3892-1
Online ISBN: 978-1-4471-3890-7
eBook Packages: Springer Book Archive